CAG vs ESPR · P/E 31, rev $11.61B vs rev $332.3M
ConAgra Foods Inc (CAG) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CAG revenue for 2025-05-25 was $11.61B. Net income was $1.15B. Revenue was down 3.6% from 2024-05-26 to 2025-05-25. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
CAG currently screens at market cap $10.02B and trailing P/E 30.9. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the CAG and ESPR stock pages for the full models.
Not investment advice.